Patients Continue To Demand Cheap Generic Life-Saving Drugs From India
News: China has a large demand for low-priced generic life-saving drugs manufactured in India, reports NZweek, citing the General Administration of Customs of China. Chinese smugglers and patients are finding ways to get the drugs despite the Chinese government banning their use, deeming them fake. Many patients in China buy anticancer drugs from pharmacies in India online at a much cheaper rate, revealed an unidentified buyer. Several generic drugs produced by Indian drugmakers are comparable to those made by international drug giants, such as Indian drugmaker Cipla's Soranib for liver cancer treatment. Costing CNY2,000(US$326.3), it is an Indian equivalent to German drugmaker Bayer's Nexavar (sorafenib), which costs CNY50,000(US$8,157.5) a month.